NCT03786016

Brief Summary

This study assesses differences in biological and behavioral domains that relate to individual adaptation and resiliency to an isolated, confined and controlled environment, and evaluates the effect of confinement, work, monotony, and social and physical isolation on stress resiliency and well-being.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 14, 2018

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 24, 2018

Completed
2 months until next milestone

Study Start

First participant enrolled

February 22, 2019

Completed
5.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 10, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
Last Updated

April 6, 2025

Status Verified

April 1, 2025

Enrollment Period

5.8 years

First QC Date

December 14, 2018

Last Update Submit

April 4, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Resilience

    Change in Resilience

    Days 1 and 8

Secondary Outcomes (7)

  • Stress

    Days 1-8

  • Biomarker-Response to Stress

    Days 2, 4, 6, 8

  • Brain Structure

    Days 1 and 8

  • Brain Function

    Days 1 and 8

  • Cognitive Performance

    Days 2-8

  • +2 more secondary outcomes

Study Arms (1)

8-Days in an Isolation, Confinement Unit

EXPERIMENTAL

Subjects will spend 7-night/8-day in an isolated and confined unit with up to 3 other subjects.

Behavioral: 8-Days in an Isolation, Confinement Unit

Interventions

Subjects will spend 8 days/7 nights continuously in an isolated and confined unit with up to 3 other subjects. Subjects will participate in daily, timed activities such as space-relevant computer simulations, team tasks, and cognitive performance testing. Subjects will also experience altered environmental conditions (such as changes in lighting, sound and ambient temperature) while in the isolation unit. Subjects will receive orders from "mission control" who will monitor activity in the isolation unit and direct subjects throughout the 8-day study.

8-Days in an Isolation, Confinement Unit

Eligibility Criteria

Age30 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 30 and 55 years
  • A master's degree (or its equivalency in work experience) in Science, Technology, Engineering and Math (STEM) or military service
  • Free of psychological/psychiatric conditions that preclude participation
  • BMI \< 35
  • Ability to read/write English

You may not qualify if:

  • History of neurological, psychiatric, or other medical condition that excludes participation
  • Current mania or psychosis
  • Current depression
  • Current poor resiliency
  • Alcohol or drug abuse in the past year based upon history and urine toxicology screen.
  • Current smoker/tobacco user.
  • Acute, chronic, or debilitating medical conditions, major Axis I psychiatric illness, epilepsy, or thyroid disease based
  • Cardiovascular, neurological, gastrointestinal, or musculoskeletal problems that exclude participation
  • For MRI testing any of the following conditions may exclude subjects from participation in the present experiment: Tinnitus; sensorineural hearing loss \> 30 decibels; pace maker or internal defibrillator; metallic implants (e.g. orthopedic plates after bone fractures, joint replacements, surgical staples or clips, artificial heart valves, stents, cava filters); metallic splinters (e.g. after an accident or due to war injury); non-removable dental brace; tattoo (some tattoo inks contain metallic particles); permanent make-up; intrauterine contraceptive device; cochlear implant (implanted hearing device); medication pump; acupuncture needle; other foreign bodies/objects which are non-removable; pregnancy (or its possibility); previous brain and/or heart surgery; and fear of tight spaces.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Stress, Psychological

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Officials

  • David Dinges, PhD

    University of Pennsylvania

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: All participants will be exposed to the same condition.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 14, 2018

First Posted

December 24, 2018

Study Start

February 22, 2019

Primary Completion

December 10, 2024

Study Completion

February 28, 2025

Last Updated

April 6, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations